- Home
- MDCX vs PRSO Comparison
MDCX vs PRSO Comparison
Compare MDCX & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MDCX | PRSO |
|---|---|---|
| Founded | 2008 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Semiconductors |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9M | 13.4M |
| IPO Year | 2025 | 2000 |
Fundamental Metrics
Financial Performance| Metric | MDCX | PRSO |
|---|---|---|
| Price | $0.15 | $0.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $14.50 | $3.00 |
| AVG Volume (30 Days) | ★ 5.6M | 235.2K |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.23 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $14,573,000.00 |
| Revenue This Year | N/A | $18.48 |
| Revenue Next Year | N/A | $53.57 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.99 |
| 52 Week Low | $0.14 | $0.46 |
| 52 Week High | $2.78 | $2.37 |
Technical Indicators
Market Signals| Indicator | MDCX | PRSO |
|---|---|---|
| Relative Strength Index (RSI) | 29.90 | 39.97 |
| Support Level | $0.15 | $0.46 |
| Resistance Level | $0.19 | $0.92 |
| Average True Range (ATR) | 0.01 | 0.03 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 14.70 | 35.13 |
Price Performance
Historical ComparisonAbout MDCX Medicus Pharma Ltd.
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.
About PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices, and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz to 300 GHz. Geographically, the company generates revenue from the United States, Hong Kong, Taiwan, Europe, and the Rest of the World.